SEC Form 4 · accession 0001554795-15-000450
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Nov 18, 2015
Accepted (ET)
Nov 18, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 18, 2015 | P | 34,000 | $0.05 | A | 9,868,621 | D | |
| Common Stock | Nov 18, 2015 | P | 20,400 | $0.06 | A | 9,889,021 | D | |
| Common Stock | Nov 18, 2015 | P | 30,400 | $0.065 | A | 9,919,421 | D | |
| Common Stock | Nov 18, 2015 | P | 85,000 | $0.07 | A | 10,004,421 | D |
Table II — derivative securities
No Table II lines on this filing.